EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 11 (Novembre 2010) Med Sci (Paris), 26 11 (2010) 950-959 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 11, Novembre 2010
Page(s) 950 - 959
Section Resistance aux antibiotiques : un enjeu international
DOI https://doi.org/10.1051/medsci/20102611950
Published online 15 November 2010
  1. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005 ; 18 : 306-25. [Google Scholar]
  2. Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 2009 ; 69 : 1879-901. [Google Scholar]
  3. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria. Lancet Infect Dis 2009 ; 9 : 228-36. [Google Scholar]
  4. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007 ; 2 : 501-12. [Google Scholar]
  5. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007 ; 20 : 440-58. [Google Scholar]
  6. Rossolini GM, Mantengoli E, Docquier JD, et al. Epidemiology of infections caused by multiresistant gram-negatives: ESBL, MBL, panresistant strains. New Microbiol 2007 ; 30 : 332-9. [Google Scholar]
  7. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008 ; 14 (Suppl 1) : 82-9. [Google Scholar]
  8. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009 ; 63 : 659-67. [Google Scholar]
  9. Lee K, Yong D, Choi YS, et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007 ; 29 : 201-6. [Google Scholar]
  10. Lartigue MF, Poirel L, Poyart C, et al. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007 ; 13 : 315-7. [Google Scholar]
  11. Carmeli Y, Akova M, Cornaglia G, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010 ; 16 : 102-11. [Google Scholar]
  12. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008 ; 52 : 1028-33. [Google Scholar]
  13. Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010 ; 16 : 112-22. [Google Scholar]
  14. Samra Z, Bahar J, Madar-Shapiro L, et al. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2008 ; 46 : 3110-1. [Google Scholar]
  15. Carrër A, Poirel L, Yilmaz M, et al. Emerging spread of OXA-48-encoding plasmid from Turkey and beyond. Antimicrob Agents Chemother 2010 ; 54 :1369-73. [Google Scholar]
  16. Gülmez D, Woodford N, Palepou MF, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008 ; 31 : 523-6. [Google Scholar]
  17. Uzun O, Hascelik G, Livermore DM. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008 ; 31 : 523-6. [Google Scholar]
  18. Poirel L, Héritier C, Nordmann P. Chromosome-encoded ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother 2004 ; 48 : 348-51. [Google Scholar]
  19. Walsh TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008 ; 21 : 367-71. [Google Scholar]
  20. Lartigue MF, Poirel L, Nordmann P. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob Agents Chemother 2004 ; 48 : 4929-30. [Google Scholar]
  21. Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother 2010 ; 54 : 471-6. [Google Scholar]
  22. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-β-lactamase gene, b/a(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009 ; 53 : 5046-54. [Google Scholar]
  23. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010 ; 10 : 597-602. [Google Scholar]
  24. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 2009 ; 58 : 1133-48. [Google Scholar]
  25. Mesaros N, Nordmann P, Plésiat P, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007 ; 13 : 560-78. [Google Scholar]
  26. Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002 ; 50 : 673-9. [Google Scholar]
  27. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009 ; 53 : 4783-8. [Google Scholar]
  28. Nordmann P, Poirel L. Acinetobacter baumannii: Basic and emerging mechanisms of resistance. Eur Infect Dis 2009 ; 2 : 94-7. [Google Scholar]
  29. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010 ; 54 : 24-38. [Google Scholar]
  30. Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009 ; 53 : 5035-8. [Google Scholar]
  31. Towner KJ. Acinetobacter : an old friend, but a new enemy. J Hosp Infect 2009 ; 73 : 355-63. [Google Scholar]
  32. Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram- negative pathogenic bacteria: β-lactams in peril! Curr Opin Microbiol 2005 ; 8 : 518-24. [Google Scholar]
  33. Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007 ; 51 : 3471-84. [Google Scholar]
  34. Desphande P, Rodrigues C, Shetty A, et al. New Delhi metallo β-lactamase (NDM-1) in Enterobacteriaceae; treatment options with carbapenems compromised. J Assoc Physicians India 2010 ; 58 ; 1-6. [Google Scholar]
  35. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010 ; 65 : 2253-4. [Google Scholar]
  36. Poirel L, Lagrutta E, Taylor P, et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010 ; 54 : 4914-6. [Google Scholar]
  37. Zahar JR, Bille E, Schnell D, et al. Diffusion communautaire des entérobactéries sécrétrices de P-lactamase à spectre élargi (EBLSE). Med Sci (Paris) 2009 ; 25 : 939-44. [Google Scholar]
  38. Pagès JM. Porines bactériennes et sensibilité aux antibiotiques. Med Sci (Paris) 2004 ; 20 : 346-51. [Google Scholar]
  39. Barbier F, Wolff M. Multirésistance chez Pseudomonas aeruginosa. Vers l’impasse thérapeutique ? MedSci (Paris) 2010 ; 26 : 960-8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.